1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
CML - 652
ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML
Poster Presenter
Authors
Part of Topic
Chronic Myeloid Leukemia (CML)
ELVN-001; chronic myeloid leukemia; CML; chronic-phase CML; CP-CML; BCR::ABL1; tyrosine kinase inhibitor; TKI; molecular response; efficacy; safety